The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,284
Sort by:
GLOBAL PROBIOTICS MARKET FORECAST 2017-2025
US$ 2,500.00
... The Probiotic market size is projected to grow from $37741 million in 2016 to $71948 million by 2025. The market is anticipated to grow at a CAGR of 7.49% during the forecast period of 2017-2025. The ...
April 2017
136 pages
Generic Drugs Market in India 2017
US$ 950.00
... placed. Netscribes’ latest market research report titled Generic Drugs Market in India 2017 covers the current and future state of the generics market in the country. ... are removed. COVERAGE: Overview of the generics drugs market in India, and historical and forecasted market size data over 2012 to 2020 Trade ...
April 2017
64 pages
Charting the Orphan Drug Development Pipeline
US$ 695.00
... /developers are setting the pace? Charting the Orphan Drug Development Pipeline analyses 3,868 unique molecules from 2,257 developers to create the most comprehensive independent analysis of orphan drug ... Overview Orphan drug market dynamics Legal definitions and incentives for orphan drug development in US and EU Trends in orphan drug designation For each therapy area covered EU/US designated drugs Orphan drugs designated ...
April 2017
-
Global Antibody Drug Conjugates (ADC) Market – Analysis By Drugs (Adcetris, Kadcyla), Pipeline Drugs, Regulations: Opportunities and Forecasts (2017-2022) - By Region (N. America, Europe, APAC, RoW); By Country (US, Canada, UK, Germany, France, Japan, China, Singapore, India, Brazil, South Africa)
US$ 1,800.00
... antibody drug conjugates market is driven by large number of ADC drugs in pipeline, rise in global incidences of cancer and wider therapeutic window offered by ADCs. According to Azoth Analytics research report, “Global Antibody Drug Conjugates (ADC ...
March 2017
154 pages
2017 U.S. Drugs of Abuse POC/Point-of-Care Testing Market: Physician Offices, Emergency Rooms, Ambulatory Care Centers-- Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review
US$ 2,250.00
... VPGMarketResearch contains 14 tables, and provides a comprehensive analysis of the POC drugs of abuse testing market, including trends, dynamics, size, growth, regulatory requirements ... sales forecasts for drugs of abuse procedures by market segment: Physician Offices/Group Practices Emergency Rooms Ambulatory Care Centers Analysis of drugs of abuse procedures Competitive ...
March 2017
165 pages
GLOBAL DRUG DISCOVERY MARKET FORECAST 2017-2024
US$ 2,500.00
... accounts for the second largest market in the global drug discovery market. Asia-Pacific market is projected to grow during the forecast period due to increase in the number of contract ...
March 2017
187 pages
2017 Shimadzu: Challenges, Technological Capabilities, Marketing Tactics, Strategic Direction in the Global Medical Imaging Industry
US$ 2,475.00
... new report from VPGMarketResearch provides insightful analysis of Shimadzu capabilities, goals and strategies in the global diagnostic imaging market. ... ultrasound, MRI, CT, nuclear medicine, PET, PACS and other technologies. The analysis of Shimadzu includes: Business, new product development, and marketing ...
March 2017
40 pages
2017 Europe Drugs of Abuse Testing Market: Future Horizons and Growth Strategies--Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities
US$ 5,850.00
... -page report from VPGMarketResearch provides a comprehensive analysis of the European drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts ... , Phencyclidine (PCP), Propoxphene.During the next five years, the abused drug testing market will undergo significant transformation. These changes will ...
March 2017
300 pages
Infectious Disease Drugs: The Chinese Market
US$ 5,500.00
This infectious disease drugs report by BCC Research analyzes infectious disease market applications, industry structure, and marketing and distribution.
March 2017
164 pages
Global Rheumatoid Arthritis Drug Market Outlook 2022
US$ 1,500.00
... Mechanism of Rheumatoid Arthritis Drugs Synthetic DMARDs as Rheumatoid Arthritis Drug Biological Agents as Rheumatoid Arthritis Drug Global Market of Rheumatoid Arthritis Drug Global Tendencies in Use of Antirheumatics Global Rheumatoid Arthritis Drug Market ...
March 2017
90 pages
US Antidiabetics Drug Market Outlook 2022
US$ 1,800.00
... market revenue was generated by Lantus, which is marketed by Sanofi. “US Antidiabetics Drug Market Outlook 2022” report highlights: US Diabetes Epidemiology US Antidiabetics Market Overview Key Marketed Antidiabetic Drugs in US US Biosimilar Insulin Market US Antidiabetics Drug Market ...
March 2017
120 pages
Orphan Drug - Global Market Outlook (2016-2022)
US$ 4,150.00
According to Stratistics MRC, the Global Orphan Drug market is estimated at $145.89 million in 2016 and is expected to reach $265.63 million by ... pharmaceutical companies on orphan drug improvement, increasing occurrence of rare diseases, government incentives for orphan medicine are some factors favouring the market growth. However ...
March 2017
148 pages
Global Ophthalmic Drugs Market Analysis & Forecast Report 2017-2022
US$ 2,600.00
The Global Ophthalmic Drugs Market Analysis & Forecast Report 2017-2022 is a professional and in-depth study on the current state of the Ophthalmic Drugs Market. The report analysis the global market of Ophthalmic Drugs by main manufactures and geographic regions. The report includes Ophthalmic Drugs definitions, classifications, applications and ...
February 2017
105 pages
Global Antibody Drug Conjugates Market By Drug (ADCETRIS, Kadcyla), Pipeline Analysis (By Phase, Mode of Action, Linker, Technology, and Indication) Outlook 2022
US$ 2,000.00
... by several Antibody Drug Conjugates (ADCs) in pipeline highlight the potential for new therapeutic innovations in this industry. According to the RNCOS report entitled “Global Antibody Drug Conjugates Market By Drug (ADCETRIS, Kadcyla), Pipeline Analysis (By Phase, Mode of Action, Linker, Technology, and Indication) Outlook 2022”, the ADC market is poised ...
February 2017
120 pages
Global Psoriasis Drugs Market by Drug Molecule (Biologic, Small Molecule Drugs), By Route of Administration (Systemic, Topical), By Mechanism of Action (TNF Inhibitors, Interleukin Blockers) Outlook 2022
US$ 2,500.00
... “Global Psoriasis Drugs Market by Drug Molecule (Biologic, Small Molecule Drugs), By Route of Administration (Systemic, Topical), By Mechanism of Action (TNF Inhibitors, Interleukin Blockers) Outlook 2022”, the global psoriasis drugs market is anticipated ... growth of the global psoriasis drugs market. The global psoriasis drugs market has been segmented on the basis of type of drug molecule into biologics drugs and small molecule/chemical drugs. Biologics are ...
February 2017
70 pages
Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Cancer Treatment Drugs Market 2017 Forecast to 2022
US$ 4,880.00
... focuses on the Cancer Treatment Drugs in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... Sciences Market Segment by Regions, regional analysis covers North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) ...
February 2017
120 pages
Europe Cancer Treatment Drugs Market by Manufacturers, Countries, Type and Application, Forecast to 2022
US$ 4,480.00
... Europe Cancer Treatment Drugs market. Chapter 1, to describe Cancer Treatment Drugs Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Cancer Treatment Drugs ...
February 2017
120 pages
Europe Paracetamol Market by Manufacturers, Countries, Type and Application, Forecast to 2022
US$ 4,480.00
... Market Segment by Applications, can be divided into Tablet Drug Granules Drug Oral Solution Others There are 17 Chapters to deeply display the Europe Paracetamol market. Chapter 1, to describe Paracetamol Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Paracetamol ...
February 2017
116 pages
Antithrombotic Drugs - Global Market Outlook (2016-2022)
US$ 4,150.00
... the factors favouring market growth. However, off- patented drugs, postoperative bleeding and availability of generic antithrombotic drugs would restrict the antithrombotic drugs market growth. Furthermore, new product launches by key vendors, up-gradation in the antithrombotic drugs and ...
February 2017
184 pages
Antiviral Drugs - Global Market Outlook (2016-2022)
US$ 4,150.00
... had given market a prudential base for the growth. Strong R&D and newer & advance formulations in the antiviral drugs market are expected to drive the market. However, high risk of failure and huge cost of R&D are hampering the market. HIV antivirals segment among ...
February 2017
148 pages
Erythropoietin Drug - Global Market Outlook (2016-2022)
US$ 4,150.00
... drugs and rising threats from thrombosis and PRCA are the factors inhibiting the market size. By Application, anemia segment leads the Erythropoietin Drugs market during the forecast period. On the other hand, retail pharmacies in end user segment dominated the global market with a huge market ...
February 2017
132 pages
Market Research and Forecast of Antineoplastic Drugs in China 2016-2021
US$ 3,500.00
... increase in China. According to statistics of ASKCI, in 2015, total output of antineoplastic drugs was about 440 tonnes, with the market scale of ... the strategy of sales in a wide range. In 2021, the forecast of China antineoplastic drug market will reach more than RMB250 billion, relatively conservative ...
January 2017
51 pages
Global Neuromyelitis Optica Drug Market by Manufacturers, Regions, Type and Application, Forecast to 2021
US$ 3,480.00
... display the global Neuromyelitis Optica Drug market. Chapter 1, to describe Neuromyelitis Optica Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Neuromyelitis Optica Drug, with ...
December 2016
115 pages
Antibody-Drug Conjugate Pipeline Review by target, drug, phase and company
US$ 880.00
Antibody-Drug Conjugate Pipeline Review by target, drug, phase and company The competitive intelligence report „Antibody-Drug Conjugate Pipeline Review by target, drug, phase and company“ evaluates and describes the competitive landscape of antibody-drug conjugates ... -specific R&D pipelines of ADCs. Competitor projects are listed in a tabular format providing information on: Drug Codes, Target/Mechanism of Action, Class of Compound (antibody, linker, payload ...
December 2016
288 pages
Global Orphan Drug Clinical Pipeline Insight 2022
US$ 3,000.00
... rare disease treatments by enhancing their pipelines or by acquiring promising molecules of smaller companies. While the orphan drug market is mostly restricted to the U.S. and Europe ...
December 2016
2200 pages
2016-2021 France Therapeutic Drug Monitoring (TDM) Market: Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts
US$ 1,960.00
... report from VPGMarketResearch.com provides a comprehensive analysis of the French therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market ... , such as specimen preparation devices, controls, calibrators and others. “2015 France Therapeutic Drug Monitoring (TDM) Market: Supplier Shares, Competitive Strategies, Country Volume and ...
November 2016
247 pages
